SEC Form 4 · accession 0001179110-16-019888
ABBOTT LABORATORIES · ABT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jean-Yves Pavee
Officer — Senior Vice President
Period of report
Feb 19, 2016
Accepted (ET)
Feb 23, 2016 · 5:40 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000001800
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Option (right to buy)F1 | $38.40 | Feb 19, 2016 | A | 194,063 | A | Feb 19, 2017 | Feb 18, 2026 | Common shares | 194,063 | 194,063 | D |
Explanation of responses
- F1Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 64,688 on 02/19/2017, 64,687 on 02/19/2018, and 64,688 on 02/19/2019.